CD8 + T cells are recognized for their role in eradicating cancer cells, disrupting immune tolerance, and amplifying the efficacy of immunotherapeutic interventions by targeting the PD-1/PD-L1 immunosuppressive axis [71]. This evidence concerns the gene CD8A and cancer.